PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 4793: Tumor-intrinsic CD80 mediates cancer stemness and vascular mimicry in aggressive oral squamous cell carcinoma

View Full Paper
YCYuehua ChenSJShih Sheng JiangSHS K Huang

Key Points

  • The aim is to explore the non-canonical roles of CD80 in promoting aggressiveness in oral squamous cell carcinoma.
  • Establishment of syngeneic OSCC sublines through in vivo selection.
  • Gene profiling and single-cell RNA sequencing of mouse tumors integrated with human data.
  • Use of shRNA knockdown, cell sorting, and tumorigenesis assays to interrogate CD80 function.
  • Assessment of SOX2's role through rescue experiments in CD80-depleted cells.
  • High CD80 expression in aggressive OSCC correlates with poor patient prognosis.
  • CD80 knockdown significantly decreased tumor burden in both immunocompetent and immunodeficient mouse models.
  • CD80 enhanced cancer stemness, indicated by increased sphere formation and SOX2 expression.
  • CD80 deficiency impaired vascular mimicry in vitro and diminished vessel-like formation.

Abstract

Abstract Background Intratumoral heterogeneity drives oral squamous cell carcinoma (OSCC) progression by fostering tumor cell plasticity. This plasticity poses a major therapeutic challenge. We identified the immune molecule CD80 as a potential driver of this process and dissected its non-canonical, tumor-intrinsic functions. Methods Syngeneic OSCC sublines were established through in vivo selection. Gene profiling and single-cell RNA sequencing (scRNA-seq) of mouse tumors, integrated with human datasets, identified candidate drivers. CD80 function was interrogated using shRNA knockdown, cell sorting, and assays of tumorigenesis, cancer stemness, and vascular mimicry (VM) in mouse models and human OSCC cells. SOX2 rescue experiments assessed mechanistic dependency. Results Gene expression profiling and scRNA-seq identified the co-stimulatory molecule CD80 as highly expressed in the aggressive sublines, and its expression correlated with poor patient prognosis in OSCC. Crucially, CD80 knockdown reduced tumor burden in immunocompetent and immunodeficient mice, demonstrating a tumor cell-intrinsic oncogenic role independent of its canonical function in adaptive immunity. Mechanistically, CD80 enhanced cancer stemness, as evidenced by increased sphere formation and SOX2 expression. In vivo scRNA-seq data indicated that CD80+ tumor cells were associated with EMT-active, metabolic, and angiogenesis pathways. Moreover, CD80 knockdown impaired vessel-like formation in vitro, while CD80-high tumors displayed prominent VM in vivo. Ectopic SOX2 expression rescued both sphere and vessel-like formation in CD80 knockdown cells, suggesting that CD80-mediated oncogenic effects are partly SOX2-dependent. Conclusions Our findings reveal a novel, non-immunological role for CD80 in driving OSCC progression. By promoting cancer stemness and VM via a CD80-SOX2 axis positions CD80 as a promising therapeutic target. Citation Format: Yu-Lin Chen, Shih Sheng Jiang, Shih-Han Huang, Ssu-Han Wang, Fang-Yu Tsai, Yen-Chung Chiu, Kai-Ping Chang, Daw-Yang Hwang, Ko-Jiunn Liu, Yu-Wen Su, Ya-Wen Chen. Tumor-intrinsic CD80 mediates cancer stemness and vascular mimicry in aggressive oral squamous cell carcinoma abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4793.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/69d1fe07a79560c99a0a46achttps://doi.org/10.1158/1538-7445.am2026-4793
Ask AI
Helpful
Bookmark
Share
View Full Paper